<?xml version="1.0" encoding="utf-8"?>
<Document>
  <Do_id>16437930</Do_id>
  <Journal>I supplementi di Tumori : official journal of Societa italiana di cancerologia ... [et al.]</Journal>
  <Doc_title>[Surgical resection of gastrointestinal stromal tumor after treatment with imatinib: clinical case].</Doc_title>
  <Doc_abstract>The stromal tumor is the most common mesenchymal tumor of the gastrointestinal tract. Surgical resection is the first-line therapy for operable lesions, however for inoperable imatinib is an effective therapy. In this setting a patient has been operated after a remarkable response to imatinib, used as both neoadjuvant and adjuvant. This approach led to a disease-free condition without toxicity and complications.</Doc_abstract>
  <Doc_ChemicalList>Antineoplastic Agents;Benzamides;Piperazines;Pyrimidines;Imatinib Mesylate</Doc_ChemicalList>
  <Doc_meshdescriptors>Adult;Antineoplastic Agents;Benzamides;Combined Modality Therapy;Gastrointestinal Stromal Tumors;Humans;Imatinib Mesylate;Male;Piperazines;Pyrimidines</Doc_meshdescriptors>
  <Doc_meshqualifiers>therapeutic use;drug therapy;surgery;therapeutic use;therapeutic use</Doc_meshqualifiers>
</Document>
